Listed by the USPTO as GOLDBERG, JEANINE ANNE
Tech Center 3700 • Art Units: 1634 1637 1682 1683 1699 3791
This examiner grants 46% of resolved cases
GOLDBERG, JEANINE ANNE is assigned to tech center 3700 and art unit 1634. The record includes 839 resolved cases, a 45.6% allowance rate, and a median of 1276 days to allowance. The 40.7% interview lift indicates a substantial association between interviews and allowance outcomes in the recorded cases.
The listed companies are The Regents of the University of California, Kao Corporation, and Hadasit Medical Research Services and Development Ltd. The listed firms are CASIMIR JONES, S.C., FOLEY & LARDNER LLP, and MARSHALL, GERSTEIN & BORUN LLP. The broad record supports using interview planning as a central part of prosecution strategy for matters assigned to this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18551126 | BIOMARKERS FOR CONFORMATION OF RIDING TRAITS IN HORSES | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18363344 | METHODS, DEVICES, AND SYSTEMS FOR DETERMINING LOW GRADE GLIOMA (LGG) SUBTYPES IDENTIFIED THROUGH MACHINE LEARNING | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18537540 | LINKED TRANSCRIPT SEQUENCING | Non-Final OA | Singular Genomics Systems, Inc. |
| 18591359 | ANALYSIS METHOD, KIT, AND DETECTION DEVICE | Non-Final OA | KABUSHIKI KAISHA TOSHIBA |
| 17402018 | GENETIC ABNORMALITIES IN PLASMA CELL DYSCRASIAS | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 18463329 | COMPOSITIONS AND METHODS FOR MOLECULAR INVERSION PROBE ASSAYS | Non-Final OA | AFFYMETRIX, INC. |
| 18241411 | COMPOSITIONS AND METHODS FOR DETECTING GYNECOLOGICAL CANCER | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18577231 | DIAGNOSING INFLAMMATORY BOWEL DISEASES | Non-Final OA | SHEBA IMPACT LTD. |
| 18251528 | MULTIPLEX DETECTION OF BACTERIAL RESPIRATORY PATHOGENS | Final Rejection | Becton, Dickinson and Company |
| 18416592 | METHOD FOR PREPARING NUCLEIC ACID SAMPLE | Non-Final OA | KAO Corporation |
| 18015311 | METHOD FOR DETECTING SEVERITY OF ATOPIC DERMATITIS | Non-Final OA | KAO CORPORATION |
| 17922565 | METHOD FOR DETECTING ATOPIC DERMATITIS | Non-Final OA | KAO CORPORATION |
| 18008146 | TREATMENTS FOR A SUB-POPULATION OF INFLAMMATORY BOWEL DISEASE PATIENTS | Non-Final OA | CEDARS-SINAI MEDICAL CENTER |
| 18285876 | ISOTHERMAL AMPLIFICATION-BASED DETECTION OF SHRIMP PATHOGENS | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 18691704 | microRNA BIOMARKERS | Non-Final OA | IMPERIAL COLLEGE INNOVATIONS LIMITED |
| 18699569 | CD274 REARRANGEMENTS AS PREDICTORS OF RESPONSE TO IMMUNE CHECKPOINT INHIBITOR THERAPY | Non-Final OA | Foundation Medicine, Inc. |
| 18391216 | PERIANAL SWAB PCR PANEL, METHODS, DEVICE, AND KITS | Non-Final OA | IDEXX Laboratories, Inc. |
| 18291113 | USE OF CIRCULATING CELL-FREE METHYLATED DNA TO DETECT TISSUE DAMAGE | Non-Final OA | Georgetown University |
| 17994090 | MARKERS AND CELLULAR ANTECEDENTS OF RHEUMATOID ARTHRITIS FLARES | Non-Final OA | The Rockefeller University |
| 18532745 | COMPOSITIONS AND METHODS FOR MUTATIONS ASSOCIATED WITH SUDDEN UNEXPECTED DEATH IN PEDIATRICS (SUDP) | Final Rejection | The Children's Medical Center Corporation |
| 18270409 | METHODS AND KITS FOR DETECTING A RISK FOR DEVELOPING NEUROLOGICAL OR NEUROPHYSIOLOGICAL DISORDERS | Final Rejection | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) |
| 17794228 | BACTERIAL QUANTIFICATION METHOD | Final Rejection | Microbio Pty Ltd |
| 18044989 | TOOLS & METHODS USEFUL FOR DETECTION OF LACTOSE INTOLERANCE AND USES THEREOF | Final Rejection | Individual inventor |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy45.6% of resolved applications examined by Jeanine Anne Goldberg were allowed (839 resolved cases), compared with 30.2% across Art Unit 1634 over the last five years.
This examiner's interview lift is +40.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jeanine Anne Goldberg took 1,276 days on average from filing to allowance.
Jeanine Anne Goldberg examines applications in Art Unit 1634 in Tech Center 3700 (Medical Devices & Mechanical Engineering).